reference/5158444

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5158444

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	240
issn	0017-5749
issueIdentifier	2
pageRange	233-240
publicationName	Gut
startingPage	233
bibliographicCitation	Kruis W, Kiudelis G, Rácz I, Gorelov IA, Pokrotnieks J, Horynski M, Batovsky M, Kykal J, Boehm S, Greinwald R, Mueller R; International Salofalk OD Study Group. Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial. Gut. 2009 Feb;58(2):233–40. PMID: 18832520; PMCID: PMC3269751.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17554a87407c37beec643699edd855a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c356adaf161439f5c270687a7cd97c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_445661a94124ec0a345d8f9679326038 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e654988acb35523032ed4114ab48f54c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e349ad41e079339bda9da6e99726f4e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f17990649cba7b9c1d8683036b684bd4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdba4385c42930b8e65ba598b7425720 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbd4eab5c4a91f5f6d5fab6ec3db69d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21e560beec8cc2ae805bd46a12b4454c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7220687749c296f0fc593516be10966 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8c50efb629d4c98afe39bd466e1ea93
date	2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18832520 https://doi.org/10.1136/gut.2008.154302 https://pubmed.ncbi.nlm.nih.gov/PMC3269751
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3923 https://portal.issn.org/resource/ISSN/0017-5749
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
discusses	http://id.nlm.nih.gov/mesh/M0001335 http://id.nlm.nih.gov/mesh/M0029386
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000894Q000008 http://id.nlm.nih.gov/mesh/D003093Q000188 http://id.nlm.nih.gov/mesh/D019804Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000894Q000627 http://id.nlm.nih.gov/mesh/D010349 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003093Q000473 http://id.nlm.nih.gov/mesh/D018401 http://id.nlm.nih.gov/mesh/D016009 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003113 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D019804Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8977 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7300 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128677367 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129113875 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136084028 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129058916 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128358759

Total number of triples: 59.